Results for antiphospholipid translation from English to Latvian

the cause of antiphospholipid syndrome is not completely known.
gada antiphospholipid sindroma cēlonis nav pilnībā zināma.

in fact, antiphospholipid antibodies have been reported in approximately 2% of the normal population.
patiesībā, antiphospholipid antivielas ir ziņots apmēram 2% no normālā populācijā.

antiphospholipid syndrome has been referred to as hughes syndrome in honor of the doctor who first described it.
antiphospholipid sindromu ir minēta kā hughes sindroms godu ārstam, kas pirmo reizi tika aprakstīta tā.

each manifestation of the antiphospholipid syndrome, and each individual patient with the condition, is treated uniquely.
katrs izpausme antiphospholipid sindroma, un katram indivīdam ar nosacījumu, uzskata unikāli.

nevertheless, the antiphospholipid antibody (a protein) is not considered a normal blood protein and has been found in patients to be associated with a number of illnesses.
tomēr, antiphospholipid antivielas (olbaltumvielu) nav uzskatāma par normālu asins olbaltumvielas un ir konstatēts pacientiem, kas ir saistītas ar slimību skaits.

known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant);
zināma iedzimta vai iegūta arteriālās trombembolijas predispozīcija, piemēram, hiperhomocisteinēmija un antifosfolipīdu antivielas (antikardiolipīna antivielas, lupus antikoagulants);

known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).
zināma iedzimta vai iegūta nosliece uz arteriālu trombemboliju, piemēram, hiperhomocisteinēmija un antifosfolipīdu antivielas (antikardiolipīna antivielas, lupus antikoagulants).

(apc-) resistance, antithrombin-iii deficiency, protein c deficiency, protein s deficiency, hyperhomocysteinemia, and antiphospholipid antibodies (anticardiolipin antibodies, lupus anticoagulant)
5 nepietiekamība, hiperhomocisteinēmija, un antivielas pret fosfolipīdiem (antivielas pret kardiolipīniem, sistēmas (vilkēdes) antikoagulanti).